All Stories

  1. A randomized clinical trial of low-dose cannabis extract in Alzheimer's disease
  2. Cerebrospinal fluid irisin and lipoxin A4 are reduced in elderly Brazilian individuals with depression: Insight into shared mechanisms between depression and dementia
  3. Age-linked suppression of lipoxin A4 associates with cognitive deficits in mice and humans
  4. Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report
  5. Functional interplay between adenosine A2A receptor and NMDA preconditioning in fear memory and glutamate uptake in the mice hippocampus
  6. Corrigendum: Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis
  7. Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis
  8. Potential clinical benefits of CBD-rich Cannabis extracts over purified CBD in treatment-resistant epilepsy: observational data meta-analysis
  9. Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus
  10. Blockade of hippocampal bradykinin B1 receptors improves spatial learning and memory deficits in middle-aged rats
  11. Adenosine A1 receptor activation modulates N-methyl-d-aspartate (NMDA) preconditioning phenotype in the brain
  12. FRIEND Engine Framework: a real time neurofeedback client-server system for neuroimaging studies
  13. Cellular prion protein (PrPC) modulates ethanol-induced behavioral adaptive changes in mice
  14. Adenosine A1 Receptor-Dependent Antinociception Induced by Inosine in Mice: Pharmacological, Genetic and Biochemical Aspects
  15. Corticosteroid–endocannabinoid loop supports decrease of fear-conditioned response in rats
  16. Neuromarketing: insightful, but not mind reading
  17. Cellular prion protein is present in dopaminergic neurons and modulates the dopaminergic system
  18. Age-Dependent Relevance of Endogenous 5-Lipoxygenase Derivatives in Anxiety-Like Behavior in Mice
  19. Erratum to: Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats
  20. Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats
  21. Correction for Pamplona et al., Anti-inflammatory lipoxin A 4 is an endogenous allosteric enhancer of CB 1 cannabinoid receptor
  22. A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers
  23. Atorvastatin and simvastatin protects cognitive impairment in an animal model of sepsis
  24. Anti-inflammatory lipoxin A 4 is an endogenous allosteric enhancer of CB 1 cannabinoid receptor
  25. Age-Related Cognitive Decline in Hypercholesterolemic LDL Receptor Knockout Mice (LDLr−/−): Evidence of Antioxidant Imbalance and Increased Acetylcholinesterase Activity in the Prefrontal Cortex
  26. Generalization of contextual fear depends on associative rather than non-associative memory components
  27. Corrigendum to “Fear relief—towards a new conceptual framework and what endocannabinoids gotta do with it” [Neuroscience 204 (2012) 159–185]
  28. Fear relief—toward a new conceptual frame work and what endocannabinoids gotta do with it
  29. Application of Mild Therapeutic Hypothermia on Stroke: A Systematic Review and Meta-Analysis
  30. Psychopharmacology of the endocannabinoids: far beyond anandamide
  31. Prolonged fear incubation leads to generalized avoidance behavior in mice
  32. Chronic caffeine treatment during prepubertal period confers long-term cognitive benefits in adult spontaneously hypertensive rats (SHR), an animal model of attention deficit hyperactivity disorder (ADHD)
  33. Early life environment determines the development of adult phobic-like fear responses in BALB/cAnN mice
  34. Altered emotionality leads to increased pain tolerance in amyloid β (Aβ1–40) peptide-treated mice
  35. Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: therapeutic potential in neurological diseases
  36. Environmental enrichment reduces the impact of novelty and motivational properties of ethanol in spontaneously hypertensive rats
  37. Aspirin-triggered lipoxin induces CB1-dependent catalepsy in mice
  38. Environmental enrichment improves cognitive deficits in Spontaneously Hypertensive Rats (SHR): Relevance for Attention Deficit/Hyperactivity Disorder (ADHD)
  39. Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorder
  40. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats
  41. Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats
  42. Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
  43. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2
  44. Increased sensitivity to cocaine-induced analgesia in Spontaneously Hypertensive Rats (SHR)
  45. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats
  46. WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors
  47. The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze
  48. Caffeine improves spatial learning deficits in an animal model of attention deficit hyperactivity disorder (ADHD) – the spontaneously hypertensive rat (SHR)
  49. Strain and sex differences in the expression of nociceptive behavior and stress-induced analgesia in rats